Ankit Gilani
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
-
- Hormonal Regulation and Hypertension
Papers in
-
- Adipose Tissue and Metabolism 4
- Nitric Oxide and Endothelin Effects 2
-
- Eicosanoids and Hypertension Pharmacology 8
- Co-authors
- Víctor Garcia (7 shared papers)Michal L. Schwartzman (8 shared papers)John R. Falck (6 shared papers)Jorge H. Capdevila (2 shared papers)James C. Lo (9 shared papers)Kevin Agostinucci (5 shared papers)Frank Fan Zhang (2 shared papers)Rambabu Dakarapu (1 shared paper)
- Journals
- The FASEB Journal (2 papers)eLife (2 papers)Comprehensive physiology (2 papers)American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Ankit Gilani
19 papers receiving 379 citations
Peers
Comparison fields: 5 of 61
- Biochemistry 154
- Endocrinology, Diabetes and Metabolism 78
- Physiology 61
- Pharmacology 20
- Pathology and Forensic Medicine 36
Countries citing papers authored by Ankit Gilani
This map shows the geographic impact of Ankit Gilani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankit Gilani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankit Gilani more than expected).
Fields of papers citing papers by Ankit Gilani
This network shows the impact of papers produced by Ankit Gilani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankit Gilani. The network helps show where Ankit Gilani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ankit Gilani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 140 | |
| 2 | 2018 | 41 | |
| 3 | 2024 | 35 | |
| 4 | 2020 | 33 | |
| 5 | 1993 | 30 | |
| 6 | 2023 | 23 | |
| 7 | 2014 | 19 | |
| 8 | 2017 | 13 | |
| 9 | 2024 | 11 | |
| 10 | 2022 | 11 | |
| 11 | 2020 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 1993 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2020 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2025 | 0 |
About Ankit Gilani
Ankit Gilani is a scholar working on Physiology, Biochemistry, Epidemiology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 21 papers that have together received 380 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (8 papers), Adipose Tissue and Metabolism (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Hormonal Regulation and Hypertension (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Diabetes and associated disorders (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cardiovascular Disease and Adiposity (2 papers). The work is most often cited by research in Biochemistry (154 citations), Endocrinology, Diabetes and Metabolism (78 citations), Physiology (61 citations), Pharmacology (20 citations) and Pathology and Forensic Medicine (36 citations). Ankit Gilani has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Víctor Garcia, Michal L. Schwartzman, John R. Falck, Jorge H. Capdevila, James C. Lo, Kevin Agostinucci, Frank Fan Zhang, Rambabu Dakarapu, Darryl C. Zeldin and Joan P. Graves. Their work appears in journals such as The FASEB Journal, eLife, Comprehensive physiology, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.